Directs the Secretary of Defense to report on emerging investigational treatments for treatment-resistant PTSD in veterans and servicemembers.
The Veterans and Servicemembers PTSD Emerging Treatment Review Act of 2026 mandates the Secretary of Defense to submit a report to Congress on emerging investigational treatment options for treatment-resistant post-traumatic stress disorder (PTSD) in veterans, members of the Armed Forces, and those transitioning to civilian life. The report must include a summary of safety, dosing, and adverse event data from a specified clinical trial, an analysis of the data's applicability to military personnel, and an assessment of the implications for force health protection, medical readiness, and.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.